Western blot examination of tumor protein extracts from the corresponding serially collected samples confirmed suppression of EGFR Y1068 phosphorylation starting from 6 hours after osimertinib dosing and was undetectable by 72 hours (Fig. 3E). This evidence concerns the gene EGFR and neoplasm.